Search for: "SCHERING-PLOUGH"
Results 201 - 220
of 404
Sort by Relevance
|
Sort by Date
22 Oct 2009, 6:02 am
(Editor's Note: This post is based on a Gibson, Dunn & Crutcher LLP memorandum by Amy Goodman and Gillian McPhee.) [read post]
19 Oct 2009, 4:30 am
” In re Schering-Plough Corp. [read post]
15 Oct 2009, 4:05 am
Schering-Plough intends to announce the results of its survey sometime during the next few months. [read post]
14 Oct 2009, 6:28 am
An amended lawsuit filed over the Schering-Plough pension plan alleges that executives at the company suspected as early as 2005 that the "Enhance" Vytorin trial was a bust. [read post]
9 Oct 2009, 10:24 am
The main targets of regulation, he stresses, are the publishers or others who dispense the freebies — who of course will have new incentives to protect themselves by controls on distribution, as did Schering-Plough in the sign above. [read post]
27 Sep 2009, 12:38 am
Merck, which is set to buy rival Schering-Plough Corp. by the end of the year, won 11 of 16 Vioxx suits at trial before agreeing to settle all claims. [read post]
15 Sep 2009, 10:52 am
Oral Argument in case: ; Schering-Plough Heal v. [read post]
11 Sep 2009, 3:00 pm
Prior to Secretary Wells' appointment, she was President of the Schering-Plough Foundation, the philanthropic arm of the Schering Plough Corporation and the Vice-President of Public Affairs at Schering-Plough Corporation. [read post]
4 Sep 2009, 12:38 am
But because Merck is trying to complete a $41 billion merger with Schering-Plough, industry analysts are closely watching this first trial to gauge Merck's potential financial liability. [read post]
3 Sep 2009, 6:16 am
The jury is asked to decide:Was Merck/Schering-Plough negligent in formulating Fosamax? [read post]
30 Aug 2009, 1:00 am
Schering-Plough Corp. v. [read post]
16 Aug 2009, 9:21 pm
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
16 Aug 2009, 11:23 am
(Editor's Note: This post is based on a Simpson Thacher & Bartlett memorandum, which first appeared as an article in the New York Law Journal.) [read post]
16 Aug 2009, 2:20 am
" Schering-Plough Corp.'s Marvelon and Cerazette pills, which contain desogestrel, generated $319 million for the Kenilworth, New Jersey-based company in the first quarter, IMS Health data show. [read post]
13 Aug 2009, 9:19 am
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
12 Aug 2009, 8:09 am
(Spicy IP) UK: Hindsight going forward: taking the risk factor into account: Lilly Icos, Pfizer Enterprises, Merck, AstraZeneca & Ors v 8pm Chemists & Ors (IP finance) US: Gene patenting debate continues – round two (Patent Docs) US: Follow-on biologics news briefs – no 7 (Patent Docs) US: BIO urges Supreme Court to reject rigid Bilski rule (PatentBIOtech) US: Cargill withdraws patent infringement case before ITC against Nantong Foreign Medicines & Health… [read post]
11 Aug 2009, 3:23 am
Schering-Plough Healthcare Products, Inc. v. [read post]
10 Aug 2009, 7:19 am
Fosamax was sold by Schering-Plough Corporation, which is being bought by Merck & Co. [read post]
7 Aug 2009, 5:18 am
The New York Times reported yesterday that Merck and Schering-Plough have agreed to pay $41.5 million to settle class claims that they withheld the results of an unfavorable clinical trial. [read post]
6 Aug 2009, 10:37 am
Merck & Co. and Schering-Plough have agreed to settle class action lawsuits over their joint cholesterol drugs, Vytorin and Zetia, in the amount of $41.5 million. [read post]
